Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Timmers
The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Dual HER2 Blockade: Preclinical and Clinical Data
Breast Cancer Research
Cancer Research
Oncology
Targeting HER2+ Breast Cancer: The TBK1/IKK-Epsilon Axis
Oncoscience
Cancer Research
Oncology
Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study
Clinical Cancer Research
Cancer Research
Oncology
Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer
Oncotarget
Oncology
Do Multifocal or Multicentric pT1a Node-Negative HER2+ Breast Cancers Get Benefit From Systemic Treatment?
Breast Cancer Research and Treatment
Cancer Research
Oncology
Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
Scientific Reports
Multidisciplinary
HER2-HER3 Dimer Quantification by FLIM-FRET Predicts Breast Cancer Metastatic Relapse Independently of HER2 IHC Status
Oncotarget
Oncology
Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines
JAMA Oncology
Cancer Research
Oncology
ZW25 Active in HER2-positive Cancers
Cancer Discovery
Oncology
